0001493152-21-028917.txt : 20211116
0001493152-21-028917.hdr.sgml : 20211116
20211116150958
ACCESSION NUMBER: 0001493152-21-028917
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211018
FILED AS OF DATE: 20211116
DATE AS OF CHANGE: 20211116
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Beyer Russell P
CENTRAL INDEX KEY: 0001889754
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39871
FILM NUMBER: 211415714
MAIL ADDRESS:
STREET 1: 2100 E 54TH STREET NORTH
CITY: SIOUX FALLS
STATE: SD
ZIP: 57104
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SAB Biotherapeutics, Inc.
CENTRAL INDEX KEY: 0001833214
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 853899721
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 W. 41ST STREET
STREET 2: SUITE 202
CITY: MIAMI BEACH
STATE: FL
ZIP: 33140
BUSINESS PHONE: (305) 204-3338
MAIL ADDRESS:
STREET 1: 300 W. 41ST STREET
STREET 2: SUITE 202
CITY: MIAMI BEACH
STATE: FL
ZIP: 33140
FORMER COMPANY:
FORMER CONFORMED NAME: Big Cypress Acquisition Corp.
DATE OF NAME CHANGE: 20201120
4
1
ownership.xml
X0306
4
2021-10-18
0
0001833214
SAB Biotherapeutics, Inc.
SABS
0001889754
Beyer Russell P
2100 E 54TH STREET NORTH
SIOUX FALLS
SD
57104
0
1
0
0
Chief Financial Officer
Common Stock
2021-10-18
4
A
0
2475
10.10
A
2475
D
Common Stock
2021-09-28
4
A
0
149
10.08
A
149
I
By spouse
Common Stock
2021-10-25
4
A
0
129
7.78
A
278
I
By spouse
Common Stock
2021-10-26
4
S
0
278
7.90
D
0
I
By spouse
Common Stock
2021-09-28
4
A
0
5
10.07
A
5
I
By daughter
Common Stock
2021-09-29
4
A
0
10
10.08
A
15
I
By daughter
This transaction occurred prior to the business combination pursuant to the Agreement and Plan of Merger, dated June 21, 2021 and as amended August 12, 2021, by and among Big Cypress Acquisition Corp., Big Cypress Merger Sub Inc., and SAB Biotherapeutics, Inc. ("Issuer"). The reporting person's obligation to disclose this transaction occurred upon the consummation of the business combination.
The sale of Issuer common stock by the reporting person's spouse reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 278 shares, with the purchase of 278 shares of Issuer's common stock as also reported herein. The reporting person has paid to Issuer, upon settlement of the sale, $15.48, representing the full amount of the profit realized in connection with the short-swing transaction.
/s/ Russell Beyer
2021-11-16